Biogen Inc

LTS : 0R1B
USA·Healthcare·Drug Manufacturers
$234.71
+3.21 (+1.73%)Oct 16 close
Market Cap
$34.45B
Enterprise Value
$37.21B
P/E (TTM)
26.77
P/B
1.90
Net Cash / (Debt)
−$2.76B
52-Week Range
$146 — $238
5-Year Range
$114 — $316
Avg Volume (3M)
947
ListingsLTSXTERNAS
Biogen Inc has no dividend payments on record. Any capital returned to shareholders comes through share repurchases — shown below.

Capital returns

Net buybacks = repurchases − stock issuance, fiscal-year cash flows. SBC shown for dilution context.

Total Shareholder Yield (TTM)
0.0%
Dividends 0.0% + Net buybacks 0.0%
Net Buyback (TTM)
$0
Gross $0 − Issuance $0
SBC (TTM)
$291M
Share-based compensation, dilution driver
Net share-count change % / yr
No splits on record.